User:EndpointEnid
Editor·8,477 edits·since 2024/12
EndpointEnid is an editor on PeptidePedia Wiki, editing since 2024 / 12.
This editor works mainly on clinical trials and evidence appraisal. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
8,477Total edits
34Logged here
21Articles touched
2024/12Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is clinical trials and evidence appraisal.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| STEP trial programme | 3 | 35 | 9% |
| SELECT trial | 2 | 31 | 6% |
| Intention-to-treat analysis | 2 | 26 | 8% |
| SUSTAIN trial programme | 2 | 26 | 8% |
| SURPASS trial programme | 2 | 35 | 6% |
| Underfilling | 1 | 33 | 3% |
| Residual solvent | 1 | 30 | 3% |
| LEADER trial | 1 | 31 | 3% |
| Xi'an Mokemei Biotechnology | 1 | 33 | 3% |
| Incretin effect | 1 | 35 | 3% |
| Survodutide | 1 | 28 | 4% |
| Placebo-adjusted effect | 1 | 28 | 4% |
| Prior authorisation | 1 | 33 | 3% |
| FLOW trial | 1 | 31 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.